Literature DB >> 10684422

Reduction of Carnitine Content by Inhibition of Its Biosynthesis Results in Protection of Isolated Guinea Pig Hearts Against Hypoxic Damage.

.   

Abstract

BACKGROUND: 3-(2,2,2-trimethylhydrazinium) propionate (THP or mildronate) is an inhibitor of carnitine biosynthesis. This study was carried out to determine whether feeding of guinea pigs with THP results in decreased myocardial-free carnitine content and, as a result, attenuates hypoxic damage in isolated and paced work-performing hearts. METHODS AND
RESULTS: Guinea pigs were administered either distilled water of 100 mg THP/kg/day orally for 10 days. The treatment resulted in about a 50% decline in myocardial-free carnitine content, from 11.1 +/- 0.2 (n = 5) to 5.6 +/- 0.2 (n = 5) µM/g dry weight of the heart. The left ventricular contractile function of the hearts was measured during normoxic perfusion (PO(2) = 590 mmHg), hypoxic perfusion (PO(2) = 149 mmHg), and reperfusion (PO(2) = 590 mmHg). In both untreated and THP-treated groups, the rate of development of intraventricular pressure (+dP/dt) under normoxic perfusion was similar; however, +dP/dt declined to about 10% of the initial rate within 20 minutes of hypoxic perfusion. In the THP-treated group of hearts, the initial decline was slower than that of the untreated animal hearts. After 20 minutes of normoxic reperfusion following 60 minutes of hypoxic perfusion, the recovery of +dP/dt and -dP/dt was greater in the THP-treated group than in the untreated group. The elevation of end-diastolic pressure during hypoxia was completely reversed by normoxic reperfusion of the THP-treated group but not in the untreated group. Mitochondria isolated from hearts from the THP-treated group after normoxic reperfusion following hypoxic perfusion exhibited better respiratory function than those from untreated hearts.
CONCLUSIONS: The data suggest that feeding guinea pigs with THP results in reduced myocardial-free carnitine content and attenuation of hypoxic and reperfusion injury in isolated hearts.

Entities:  

Year:  1996        PMID: 10684422     DOI: 10.1177/107424849600100307

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol Ther        ISSN: 1074-2484            Impact factor:   2.807


  3 in total

1.  MET-88, a gamma-butyrobetaine hydroxylase inhibitor, improves cardiac SR Ca2+ uptake activity in rats with congestive heart failure following myocardial infarction.

Authors:  Y Hayashi; H Ishida; M Hoshiai; K Hoshiai; T Kirimoto; T Kanno; M Nakano; K Tajima; H Miyake; N Matsuura; H Nakazawa
Journal:  Mol Cell Biochem       Date:  2000-06       Impact factor: 3.396

2.  The methylester of gamma-butyrobetaine, but not gamma-butyrobetaine itself, induces muscarinic receptor-dependent vasodilatation.

Authors:  Maija Dambrova; Stefan Chlopicki; Edgars Liepinsh; Olga Kirjanova; Olga Gorshkova; Valery I Kozlovski; Staffan Uhlen; Inta Liepina; Ramona Petrovska; Ivars Kalvinsh
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-04-02       Impact factor: 3.000

3.  Inhibited Carnitine Synthesis Causes Systemic Alteration of Nutrient Metabolism in Zebrafish.

Authors:  Jia-Min Li; Ling-Yu Li; Xuan Qin; Pascal Degrace; Laurent Demizieux; Samwel M Limbu; Xin Wang; Mei-Ling Zhang; Dong-Liang Li; Zhen-Yu Du
Journal:  Front Physiol       Date:  2018-05-09       Impact factor: 4.566

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.